biomed devic servic
top pick reason cap stellar
robust guid buy pt
bottom line reiter buy rate follow result came
cg/street expect sale y/i organ
came cg/street estim strength
driven momentum across entir portfolio particularli knees/mako
instrument neurotech oper adj ep beat cg/consensu
adj om came estim y/i
oper leverag continu benefit execut compani ctg cost
save initi despit dilut invest om headwind
net-net continu view compel asset large-cap med-tech
believ core posit growth-ori investor given view
stable/improv market fundament robust new product cycl opportun
durabl oper leverag thesi deliv upsid guidanc remain
intact compani continu take market share across board benefit
meaning halo effect mako placement improv capit equip
market someth expect continue/acceler note underli
new product cycl medsurg neurotech/spin support fundament
momentum across market someth feel lost major
revenu detail chang exclud impact report
sale growth organ support us sale growth
sale growth xfx orthoped grew xfx
strong perform us/ou knee xfx offset weak us
trauma/extrem xfx impact suppli issu medsurg
saw continu stellar growth xfx driven strength instrument
medic xfx xfx respect
neurotech spine also strong post xfx growth driven
demand neurotech intervent spine product earli contribut
guidanc gave organ revenu guidanc someth
think posit upsid given on-going momentum across us ortho
medsurg neurotech heel new product launch well continu
mako adopt strong market backdrop capit equip ep guidanc
rang y/i
mako place mako system ww inclus system place us
prior year mako procedur total
tka q/q y/i place system competit
account line histor norm reinforc thesi competit share gain
across entir product portfolio lastli note place mako
ortho hospit demonstr earli natur opportun potenti
continu momentum beyond earli clinic data begin trickl
price close busi januari
develop manufactur market devic
instrument orthoped
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
provid full-year organ revenu growth guidanc
adjust ep guidanc adjust ep expect
rang guidanc includ impact
capit expenditur stabl price headwind unfavor
impact fx
chang estim
made follow chang estim
figur chang estim
large-cap medic devic comp group trade mean price-to-earnings multipl
given consist execut strong growth profil high end
peer group think stock justifi premium comp group sum
maintain price target price target util multipl appli
pro-forma ep estim
figur matrix discount rate impli share price target
buy unchang target price januari
biomed devic servic
except ep newold newold newold revenu oper net pe multipl price metric use price-to-earnings valuat analysisbroad large-cap medic devic price-to-earnings multipl forma
stryker
one world lead medic technolog compani
broadly-bas rang product orthoped signific presenc
medic specialti compani product includ implant use joint
replac trauma spinal surgeri surgic equip surgic
navig system endoscop commun system patient handl
emerg medic equip medic devic product use varieti
buy unchang target price januari
biomed devic servic
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
buy unchang target price januari
biomed devic servic
stryker corpor quarterli incom statementcanaccord genuiti kyle except per share good technolog special oper ex chg oper ex chg erest incom incom incom ex one-tim chg incom ex one-tim ep ex one-tim chg ep ex acq relat gross oper ex chg oper ex chg ex net charg net ex one-tim growth oper net incom charg ep charg ep ex acq growth net incom charg ep charg ep ex acq
buy unchang target price januari
biomed devic servic
stryker corpor revenu mixcanaccord genuiti kyle mix us y/i y/i xfx/x q/q q/q mixdomest stryker
